Elisabet Lindqvist

Title: Elisabet Lindqvist: Innovator in Pharmaceutical Aerosol Formulations

Introduction

Elisabet Lindqvist is a notable inventor based in Lund, Sweden. She has made significant contributions to the field of pharmaceutical aerosol formulations. With a total of 2 patents, her work focuses on improving drug delivery systems for inhalation therapies.

Latest Patents

Lindqvist's latest patents include innovative aerosol drug formulations. One patent details aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides. This formulation is designed for use in pressurized metered dose inhalers, combining a hydrofluoroalkane propellant, a medicament for inhalation, and a surfactant. The surfactant can be a C–C fatty acid or salt, a bile salt, a phospholipid, or an alkyl saccharide. Another patent focuses on aerosol formulations of peptides and proteins. This formulation comprises a HFA propellant, a pharmaceutically active polypeptide, and a surfactant that enhances systemic absorption in the lower respiratory tract.

Career Highlights

Elisabet Lindqvist is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her work at AstraZeneca has allowed her to develop and refine her innovative aerosol formulations, contributing to advancements in respiratory therapies.

Collaborations

Throughout her career, Lindqvist has collaborated with esteemed colleagues, including Ann Charlotte Johansson and Kjell Bäckström. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical field.

Conclusion

Elisabet Lindqvist's contributions to aerosol drug formulations have the potential to significantly impact the treatment of respiratory conditions. Her innovative work continues to advance the field of pharmaceutical sciences.